Last reviewed · How we verify
Pilot Study of Novel Topical Drug (Photocil) for the Treatment of Atopic Dermatitis
Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of atopic dermatitis.
Details
| Lead sponsor | Applied Biology, Inc. |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 7 |
| Start date | 2013-08 |
| Completion | 2014-12 |
Conditions
- Atopic Dermatitis
Interventions
- Photocil for Atopic Dermatitis
- Placebo - Sunscreen (SPF 2)
Primary outcomes
- Number of Pruritus Events in Last 30 Days — 30 days from baseline
Countries
United States